Currently, posts about Green Cross are surging on portal sites and stock market communities. Today, foreign investors made a net purchase of 9,525 shares of Green Cross, while institutional investors recorded a net sale of 33,000 shares, according to provisional data. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.


As of 1:30 p.m. on January 4, Green Cross shares are trading at 433,500 KRW, up 6.77% from the previous day. The trading volume stands at 661,951 shares, which is 136.73% of the five-day average trading volume.


Besides Green Cross, investor posts are also rapidly increasing for Green Cross Holdings (005250), L&K Bio (156100), and Chong Kun Dang (185750).



※ Source: AI investment assistant AI Rasilo


※ This article was automatically generated in real time by a news algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing